Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03847987 · ClinicalTrials.gov registry record · Phase 1
A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation and the Effect of Food and Taste Assessment on the Tablet Formulation in Healthy Participants
A Phase 1 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT03847987 is a Phase 1 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 24 participants.
The verdict
NCT03847987, a Phase 1 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a two-part, open-label, healthy volunteer study. Part I will investigate the relative bioavailability of capsule and tablet formulations of RO7017773. Part II will explore how the taste of the tablet formulation is perceived with and without added sweetener/flavoring.
Interventions
- DRUG RO7017773 Phase I Capsule
- DRUG RO7017773 Phase II Tablet Unflavored
- DRUG RO7017773 Phase II Tablet Sweetened/Flavored
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-03-12 |
| Est. Completion | 2019-04-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03847987
The ClinicalTrials.gov registry entry for NCT03847987 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which RO7017773 Phase I Capsule is the first listed.
NCT03847987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03847987 about?
NCT03847987 is a clinical study titled "A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation and the Effect of Food and Taste Assessment on the Tablet Formulation in Healthy Participants". This is a two-part, open-label, healthy volunteer study. Part I will investigate the relative bioavailability of capsule and tablet formulations of RO7017773. Part II will explore how the taste of the tablet formulation is perceived with and without added sweetener/flavoring.
What is the current status of trial NCT03847987?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2019-03-12. Estimated completion is 2019-04-22.
What interventions are being tested in trial NCT03847987?
The interventions under investigation include: RO7017773 Phase I Capsule (DRUG), RO7017773 Phase II Tablet Unflavored (DRUG), RO7017773 Phase II Tablet Sweetened/Flavored (DRUG).
Who is sponsoring clinical trial NCT03847987?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.